Yumanity To Reverse Merge With Kineta Two Years After Its Own Public Debut

 
• By Joseph Haas

After its August 2020 reverse merger, neuroscience-focused Yumanity is calling it quits with two transactions: an asset sale to Janssen and a merger with private cancer immunotherapy firm Kineta.

Concept Image For Deals
Yumanity is reverse merging with Kineta, enabling the latter to go public • Source: Alamy

More from Deals

More from Business